Ten Don’ts by the American Society for Reproductive Medicine
Adapted from "Ten Things Physicians and Patients Should Question" by ASRM
How This List Was Created
The Practice Committee of the American Society for Reproductive Medicine (ASRM) reviewed evidence from ASRM’s practice documents to identify possible topics along with suggestions for possible topics from the ASRM Board of Directors.
The ASRM Board of Directors and Practice Committee are comprised of representatives from every aspect of reproductive medicine through our five affiliated societies including the Society for Assisted Reproductive Technology, the Society of Reproductive Surgeons, the Society for Reproductive Endocrinology and Infertility, the Society for Male Reproduction and Urology and the Society of Reproductive Biologists and Technologists.
Please use the above link for an explanation of these ten don’ts.
- Don’t perform routine diagnostic laparoscopy for the evaluation of unexplained infertility.
- Don’t perform advanced sperm function testing, such as sperm penetration or hemizona assays, in the initial evaluation of the infertile couple.
- Don’t perform a postcoital test (PCT) for the evaluation of infertility.
- Don’t order thrombophilia testing on patients undergoing infertility evaluation.
- Don’t perform immunological testing as part of the routine infertility evaluation.
- Don’t obtain a karyotype as part of the initial evaluation for amenorrhea.
- Don’t prescribe testosterone or testosterone products to men contemplating or attempting to initiate a pregnancy.
- Don’t obtain follicle-stimulating hormone (FSH) levels in women in their 40s to identify the menopausal transition as a cause of irregular or abnormal menstrual bleeding.
- Don’t perform an endometrial biopsy in the evaluation of infertility.
- Don’t perform prolactin testing as part of the infertility evaluation in women with regular menses.